| scholarly article | Q13442814 |
| P50 | author | Rosa María Martín-Mateos | Q82687659 |
| P2093 | author name string | C Arocena | |
| F J García-Alonso | |||
| C Blesa | |||
| M García González | |||
| R Bárcena | |||
| A Albillos | |||
| F García-Hoz | |||
| J Graus | |||
| M A Rodríguez Gandía | |||
| P2860 | cites work | Initial immunosuppression in liver transplant recipients with impaired renal function | Q36357256 |
| Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. | Q37624603 | ||
| Immunosuppression in liver transplant recipients with renal impairment | Q37818993 | ||
| Economic analysis of basiliximab in renal transplantation | Q43660951 | ||
| End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment | Q43843805 | ||
| Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation | Q44291424 | ||
| Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity | Q44608676 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. | Q45072978 | ||
| The renal-sparing efficacy of basiliximab in adult living donor liver transplantation | Q46721018 | ||
| Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. | Q50574242 | ||
| A prospective economic evaluation of basiliximab (Simulect) therapy following renal transplantation | Q73117695 | ||
| Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis | Q73968473 | ||
| Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months | Q79439023 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunosuppression | Q1455316 |
| P304 | page(s) | 2570-2572 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Initial immunosuppression with or without basiliximab: a comparative study | |
| P478 | volume | 44 |
| Q44060383 | Aspergillosis after liver transplantation in the context of common variable immunodeficiency: case report |
| Q39012988 | Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: A systematic review and meta-analysis |
| Q53812212 | Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody. |
| Q34134224 | Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4+ T cells |
| Q38214975 | Peritonitis caused by Blastomyces dermatitidis in a kidney transplant recipient: case report and literature review |
| Q34937253 | Retracted: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma |
Search more.